Caplacizumab to treat immune-mediated thrombotic thrombocytopenic purpura

Poullin, P; Bornet, C; Veyradier, A; Coppo, P

Coppo, P (reprint author), Hop St Antoine, Serv Hematol, Paris, France.; Coppo, P (reprint author), Hop St Antoine, Ctr Reference Microangiopathies Thrombot, Paris, France.

DRUGS OF TODAY, 2019; 55 (6): 367

Abstract

Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare and life-threatening disease characterized by microangiopathic hemolytic anemia, ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索